The 5 analysts offering 12-month price forecasts for AxoGen Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 15.00. The median estimate represents a +78.76% increase from the last price of 9.51.
The current consensus among 6 polled investment analysts is to Buy stock in AxoGen Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.11
Reporting Date Feb 20
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.